Methods for reducing the risk of an adverse dronedarone / beta-blockers interaction in a patient suffering from atrial fibrillation

Details for Australian Patent Application No. 2010202742 (hide)

Owner Sanofi-Aventis

Inventors Radzik, Davide

Agent A J Park

Pub. Number AU-A-2010202742

Filing date 30 June 2010

Wipo publication date 19 January 2012

International Classifications

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61P 9/06 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

15 July 2010 Complete Application Filed

19 January 2012 Application Open to Public Inspection

  Published as AU-A-2010202742

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010202743-Compositions and methods for growth of pluripotent cells

2010202741-Dynamic chunking for media streaming